Navigation Links
Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting

rd-looking statements as a result of events occurring after the date of this press release.

CONTACT: Investors, Clay A. Kramer, , or Media, CarneyNoensie, , both of Burns McClellan, Inc.,+1-212-213-0006, for Biodel Inc. ckramer@burnsmc.com cnoensie@burnsmc.com

Web site: http://www.biodel.com/

Ticker Symbol: (NASDAQ-NMS:BIOD)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/9/2008)... Agency biologists will play key role in nationa...ildlife Conservation Education Specialist, Pennsy...ny the following article are available from the,Ga...us ) by clicking on "Release,#049-08.", HARRISB...nsylvania Game,Commission has found itself on a ne...
(Date:5/9/2008)... TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Os...ting condition that affects almost 50,million peop...tion of,cartilage in bone joints. The novel invest...acting oral analgesic, provided significant relief... those treated with,placebo, and with fewer gastro...
(Date:5/9/2008)... Novel Pain Medicine Studied in Patients Followi...re-USNewswire/ -- Many foot-surgery,patients exper...val of a,bunion, one of the most common foot surge...ol provided significant relief for patients who ha...cebo. Treatment with tapentadol,also resulted in p...
(Date:5/9/2008)... SAN DIEGO, May 9 /- Arde...cused on the discovery and development of,small- m...cer and,inflammatory diseases, including gout, tod...Senior Vice President, Finance and Operations and ... will resign from our board of,directors shortly t...
Breaking Medicine Technology:White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6January American Naturalist highlights 9100 1January American Naturalist highlights 9100 2January American Naturalist highlights 9100 3January American Naturalist highlights 9100 4January American Naturalist highlights 9100 5January American Naturalist highlights 9100 6January American Naturalist highlights 9100 7January American Naturalist highlights 9100 8January American Naturalist highlights 9100 9January American Naturalist highlights 9100 10January American Naturalist highlights 9100 11January American Naturalist highlights 9100 12January American Naturalist highlights 9100 13Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 9098 1Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 9098 2Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement 9096 1RxElite Registration Statement Suspended 9094 1RxElite Registration Statement Suspended 9094 2
...Jun-2007 / Karo Bio (STO:KARO) successful,KB2115 P...k proof,of concept phase II study with KB2115 in p...mpleted. KB2115 is efficacious in LDL,lowering and...reflecting effects on heart, bone, muscle and thyr...s a key regulator of,metabolic pathways and holds ...
... Congress of the European Hematology,Association, ... Favrille,Inc. , a biopharmaceutical company deve...r the treatment of cancer, announced,interim data ...nts,with indolent B-cell non-Hodgkin,s lymphoma (N... European Hematology Association in,Vienna on Satu...
Other Medicine Technology:Karo Bio Announces Sucessfule Phase II Results of KB2115 2Karo Bio Announces Sucessfule Phase II Results of KB2115 3Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3
(Date:5/12/2008)... Reports Record Quarterly Sales of over $25 ...rstCall/ -- Medifast, Inc.,(NYSE: MED ) announced...iod,ended March 31, 2008., Financial highlights...5%;, -- Gross margins increased to 75.8% vs. 74.8...Life experienced sales increase of 63% year-ov...
(Date:5/12/2008)...use Bill Gives FDA Regulatory Authority Over Tobac...- Esperanza, the largest,Hispanic faith-based orga...port of H.R. 1108, "The Family Smoking Prevention ...A regulatory authority over tobacco products., ...slation this year.,H.R. 1108 has broad bi-partisan...
(Date:5/11/2008)...VADA CITY, Calif., May 11 /PRNewswire/ -- The Myan... ) is a coalition of private American and,Myanmar ...directly to the,victims bypassing bureaucratic bar...and a myriad of supplies are being distributed., ...American and Myanmar,citizens with headquarters in...
(Date:5/11/2008)...l Three Crew Members were Fatally Injured; No Pati...tCall/ -- Air Methods Corporation,(Nasdaq: AIRM )...e,helicopters serving the University of Wisconsin ...d Saturday night around 10:30 p.m. CST after,deliv...hysician, and flight,nurse received fatal injuries...
Breaking Medicine News(10 mins):Health News:Medifast Announces First Quarter 2008 Financial Results 2Health News:Medifast Announces First Quarter 2008 Financial Results 3Health News:Medifast Announces First Quarter 2008 Financial Results 4Health News:Medifast Announces First Quarter 2008 Financial Results 5Health News:Medifast Announces First Quarter 2008 Financial Results 6Health News:Medifast Announces First Quarter 2008 Financial Results 7Health News:Medifast Announces First Quarter 2008 Financial Results 8
...s of last year hover around 2 million people, acco...rld Health Organization has suggested an intellige...ica. The WHO has advised that the influence of T...althcare in Africa could be used to give an impetu...
...n overdose of chemotherapy drugs. The Alberta Canc...r. Tony Fields told a news conference on Thursday,...e incident. She died from internal bleeding and mu... our worst nightmares," said Fields, the cancer bo...
...or asthmatic people to control their symptoms will... like Martin Comerford, a hurler from Kilkenny, fo...rom Kerry and referee Brian Gavin have not let the...pact on their lives. Asthma Control Month is bein...
...ve found that a glass of orange juice every day co...ny other citrus juices like lemonade. // The study...n the October. 26 issue of the Clinical Journal of...ndicates though many people are of the assumption ...
Other Medicine News:Health News:Overdose of Chemotherapy Drug kills a woman 2Health News:A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay 2
The Portex® ULTRAperc® Percutaneous Dilation Tracheostomy Kits allow the percutaneous insertion of a tracheostomy tube using the widely accepted Seldinger technique by means of a single-stage
Self-contained kits provide convenience and cost control. , ,Our full range of tracheostomy care trays offer a variety of wound dressing components for the effective care and management of the trach
Disposable tracheostomy care tray.
Disposable tracheostomy care tray.
Medicine Products: